BRPI1007779A2 - perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina - Google Patents

perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina

Info

Publication number
BRPI1007779A2
BRPI1007779A2 BRPI1007779A BRPI1007779A BRPI1007779A2 BR PI1007779 A2 BRPI1007779 A2 BR PI1007779A2 BR PI1007779 A BRPI1007779 A BR PI1007779A BR PI1007779 A BRPI1007779 A BR PI1007779A BR PI1007779 A2 BRPI1007779 A2 BR PI1007779A2
Authority
BR
Brazil
Prior art keywords
hcm
treatment
perexillin
perexilin
treatment method
Prior art date
Application number
BRPI1007779A
Other languages
English (en)
Inventor
Houman Ashrafian
Michael Paul Frenneaux
Original Assignee
Heart Metabolics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40833905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1007779(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Heart Metabolics Ltd filed Critical Heart Metabolics Ltd
Publication of BRPI1007779A2 publication Critical patent/BRPI1007779A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
BRPI1007779A 2009-05-13 2010-05-11 perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina BRPI1007779A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0908193.6A GB0908193D0 (en) 2009-05-13 2009-05-13 Treatment of disease state
PCT/GB2010/050770 WO2010131033A1 (en) 2009-05-13 2010-05-11 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)

Publications (1)

Publication Number Publication Date
BRPI1007779A2 true BRPI1007779A2 (pt) 2016-02-23

Family

ID=40833905

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007779A BRPI1007779A2 (pt) 2009-05-13 2010-05-11 perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina

Country Status (14)

Country Link
US (2) US8697728B2 (pt)
EP (1) EP2429525A1 (pt)
JP (2) JP2012526792A (pt)
CN (2) CN102481297A (pt)
AU (1) AU2010247120B2 (pt)
BR (1) BRPI1007779A2 (pt)
CA (1) CA2799087A1 (pt)
CL (1) CL2011002862A1 (pt)
GB (1) GB0908193D0 (pt)
IL (1) IL216288A0 (pt)
MX (1) MX338099B (pt)
NZ (1) NZ597031A (pt)
WO (1) WO2010131033A1 (pt)
ZA (1) ZA201109184B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405381D0 (en) 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure
WO2010133815A1 (en) 2009-05-20 2010-11-25 Heart Metabolics Limited Treatment of heart failure with normal ejection fraction
GB0908193D0 (en) 2009-05-13 2009-06-24 Albright Patents Treatment of disease state
WO2014036603A1 (en) * 2012-09-05 2014-03-13 Adelaide Research & Innovation Pty Ltd Uses of (-)-perhexiline
US9340443B2 (en) 2012-12-13 2016-05-17 Corning Incorporated Bulk annealing of glass sheets
SMT202000071T1 (it) * 2013-06-21 2020-03-13 Myokardia Inc Composti di pirimidinadione contro le condizioni cardiache
CN106457758B (zh) 2014-04-09 2018-11-16 康宁股份有限公司 装置改性的基材制品及其制备方法
EP3297824A1 (en) 2015-05-19 2018-03-28 Corning Incorporated Articles and methods for bonding sheets with carriers
EP3313799B1 (en) 2015-06-26 2022-09-07 Corning Incorporated Methods and articles including a sheet and a carrier
WO2017153850A1 (en) * 2016-03-07 2017-09-14 Heart Metabolics Limited Perhexiline dosing regimens for use in the treatment of hypertrophic cardiomyopathy
TW201825623A (zh) 2016-08-30 2018-07-16 美商康寧公司 用於片材接合的矽氧烷電漿聚合物
TWI810161B (zh) 2016-08-31 2023-08-01 美商康寧公司 具以可控制式黏結的薄片之製品及製作其之方法
JP7260523B2 (ja) 2017-08-18 2023-04-18 コーニング インコーポレイテッド ポリカチオン性高分子を使用した一時的結合
CN111615567B (zh) 2017-12-15 2023-04-14 康宁股份有限公司 用于处理基板的方法和用于制备包括粘合片材的制品的方法
CA3157629A1 (en) * 2019-11-10 2021-05-14 MyoKardia, Inc. Methods of treatment with myosin modulator
IT202400006796A1 (it) 2024-03-27 2025-09-27 Univ Degli Studi Magna Graecia Di Catanzaro Formulazione farmaceutica composta da peptide-c per la prevenzione della cardiomiopatia diabetica

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN380695A0 (en) 1995-06-23 1995-07-20 Queen Elizabeth Hospital, The Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions
US20030162824A1 (en) 2001-11-12 2003-08-28 Krul Elaine S. Methods of treating or preventing a cardiovascular condition using a cyclooxygenase-1 inhibitor
CL2004000366A1 (es) 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
GB0405381D0 (en) 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure
WO2005097121A1 (en) 2004-04-06 2005-10-20 Angiogenetics Sweden Ab Angiogenesis-affecting compounds and methods of use thereof
WO2010133815A1 (en) 2009-05-20 2010-11-25 Heart Metabolics Limited Treatment of heart failure with normal ejection fraction
GB0723100D0 (en) 2007-11-23 2008-01-02 Heart Metabolics Ltd Treatment of HFnEF
GB0908193D0 (en) 2009-05-13 2009-06-24 Albright Patents Treatment of disease state

Also Published As

Publication number Publication date
US20140194466A1 (en) 2014-07-10
CA2799087A1 (en) 2010-11-18
JP2012526792A (ja) 2012-11-01
AU2010247120B2 (en) 2016-06-02
MX338099B (es) 2016-04-01
CN102481297A (zh) 2012-05-30
JP2015232019A (ja) 2015-12-24
US8697728B2 (en) 2014-04-15
CL2011002862A1 (es) 2012-07-20
EP2429525A1 (en) 2012-03-21
MX2011012131A (es) 2012-03-07
NZ597031A (en) 2014-04-30
US20120122925A1 (en) 2012-05-17
ZA201109184B (en) 2012-08-29
WO2010131033A1 (en) 2010-11-18
CN107296810A (zh) 2017-10-27
AU2010247120A1 (en) 2012-01-19
IL216288A0 (en) 2012-01-31
GB0908193D0 (en) 2009-06-24

Similar Documents

Publication Publication Date Title
BRPI0916472A2 (pt) dispositivo de tratamento de ferimento, método para tratamento de um ferimento e dispositivo de tratamento de ferimento
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BR112012000882A2 (pt) Preparação cosmética capilar e método para aplicação.
BRPI0924622A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso.
BRPI0913227A2 (pt) método, e objeto
BRPI0820212A2 (pt) Dispositivo para tratamento de fraturas, método para tratamento de fraturas, e, kit para tratamento de fraturas
BRPI0919575A2 (pt) método, e, composição
BR112013013584A2 (pt) endoscópio, e, método
BRPI0817292A2 (pt) Método e aparelho para completação de poços.
BRPI0823277A2 (pt) Composição, e , método
BR112013010725A2 (pt) método, e, composição
BRPI0819819A2 (pt) Preparações, método e kits ùteis para o tratamento de tosse
BRPI1009598A2 (pt) aparelho para redução do ronco, método para redução do ronco e programa de computador para redução do ronco
BR112012018101A2 (pt) aparelho, e método.
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BR112012001172A2 (pt) artigo, e, método
BRPI0905851A2 (pt) Métodos, sistemas, e dispositivos para realizar procedimentos eletrocirúrgicos
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112012031232A2 (pt) método, dispositivo e uso
BRPI0916787A2 (pt) artigo, e, método para fabricar um artigo
BRPI0809573A8 (pt) composição, e, método
BRPI1006996A2 (pt) composição, método e uso
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
BRPI1009317A2 (pt) aparelho de formação de imagem, método de formação de imagem, e programa.
GB201305198D0 (en) Kits, components and methods for tissue reconstruction

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]